Inotiv Inc (NOTV) - Total Liabilities
Based on the latest financial reports, Inotiv Inc (NOTV) has total liabilities worth $625.32 Million USD as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. See working capital position of Inotiv Inc to evaluate short-term liquidity relative to the company's equity base.
Inotiv Inc - Total Liabilities Trend (1997–2025)
This chart illustrates how Inotiv Inc's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see NOTV total asset value.
Inotiv Inc Competitors by Total Liabilities
The table below lists competitors of Inotiv Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Fitness Champs Holdings Limited Common Stock
NASDAQ:FCHL
|
USA | $1.22 Million |
|
Barakah Offshore Petroleum Bhd
KLSE:7251
|
Malaysia | RM83.02 Million |
|
Peel Hunt Ltd
LSE:PEEL
|
UK | GBX641.21 Million |
|
Kezar Life Sciences Inc
NASDAQ:KZR
|
USA | $2.76 Million |
|
Silver Spruce Resources Inc
V:SSE
|
Canada | CA$533.19K |
|
Consolidated Firstfund Capital Corp
V:FFP
|
Canada | CA$170.84K |
|
Biomx Inc
NYSE MKT:PHGE
|
USA | $15.68 Million |
Liability Composition Analysis (1997–2025)
This chart breaks down Inotiv Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See NOTV equity to assets ratio to measure how much of total assets are equity-financed.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.27 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 8.11 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.89 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Inotiv Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Inotiv Inc (1997–2025)
The table below shows the annual total liabilities of Inotiv Inc from 1997 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-09-30 | $635.09 Million | +3.97% |
| 2024-09-30 | $610.86 Million | +3.88% |
| 2023-09-30 | $588.04 Million | -2.50% |
| 2022-09-30 | $603.13 Million | +178.29% |
| 2021-09-30 | $216.73 Million | +301.37% |
| 2020-09-30 | $54.00 Million | +72.68% |
| 2019-09-30 | $31.27 Million | +53.40% |
| 2018-09-30 | $20.38 Million | +70.58% |
| 2017-09-30 | $11.95 Million | -12.65% |
| 2016-09-30 | $13.68 Million | +4.46% |
| 2015-09-30 | $13.10 Million | -8.01% |
| 2014-09-30 | $14.24 Million | -11.77% |
| 2013-09-30 | $16.14 Million | -7.17% |
| 2012-09-30 | $17.39 Million | +3.73% |
| 2011-09-30 | $16.76 Million | -12.14% |
| 2010-09-30 | $19.08 Million | -2.00% |
| 2009-09-30 | $19.46 Million | -13.69% |
| 2008-09-30 | $22.55 Million | -3.96% |
| 2007-09-30 | $23.48 Million | -5.92% |
| 2006-09-30 | $24.96 Million | -11.62% |
| 2005-09-30 | $28.24 Million | +3.16% |
| 2004-09-30 | $27.38 Million | +8.38% |
| 2003-09-30 | $25.26 Million | +73.43% |
| 2002-09-30 | $14.56 Million | +43.54% |
| 2001-09-30 | $10.15 Million | -4.29% |
| 2000-09-30 | $10.60 Million | +19.11% |
| 1999-09-30 | $8.90 Million | +61.82% |
| 1998-09-30 | $5.50 Million | -38.89% |
| 1997-09-30 | $9.00 Million | -- |
About Inotiv Inc
Inotiv, Inc. provides nonclinical and analytical drug discovery and development services to the pharmaceutical and medical device industries in the United States, the Netherlands, and internationally. The company operates through two segments, Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). The DMS segment manufactures scientific instruments for life sciences researc… Read more